Tumor Burden Is Not Associated with Efficacy of Immune Checkpoint Inhibitors in Advanced Lung Cancer

被引：0
|
作者：
Gerber, D. [1 ]
Popat, V. [1 ]
Lu, R. [1 ]
Saltarski, J. [1 ]
Gloria-Mccutchen, Y. [1 ]
Fattah, F. [1 ]
Park, J. [1 ]
Xie, Y. [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Computed tomography; Lung cancer; Immunotherapy;
D O I：
10.1016/j.jtho.2019.08.974
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.04-71
引用
收藏
页码：S469 / S469
页数：1
相关论文
共 50 条
  • [41] Impact of opioid analgesics on the efficacy of immune checkpoint inhibitors in a lung cancer population
    Xiaoyuan Yu
    Li Zhao
    Bin Song
    BMC Pulmonary Medicine, 22
  • [42] Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma
    Domblides, Charlotte
    Leroy, Karen
    Monnet, Isabelle
    Mazieres, Julien
    Barlesi, Fabrice
    Gounant, Valerie
    Baldacci, Simon
    Mennecier, Bertrand
    Toffart, Anne-Claire
    Audigier-Valette, Clarisse
    Doucet, Ludovic
    Giroux-Leprieur, Etienne
    Guisier, Florian
    Ricordel, Charles
    Molinier, Olivier
    Perol, Maurice
    Pichon, Eric
    Robinet, Gilles
    Templement-Grangerat, Dorine
    Ruppert, Anne-Marie
    Rabbe, Nathalie
    Antoine, Martine
    Wislez, Marie
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (05) : 860 - 866
  • [43] Lung cancer, elderly and immune checkpoint inhibitors
    Casaluce, Francesca
    Sgambato, Assunta
    Maione, Paolo
    Spagnuolo, Alessia
    Gridelli, Cesare
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1474 - S1481
  • [44] Using Immune Checkpoint Inhibitors in Lung Cancer
    Marrone, Kristen A.
    Brahmer, Julie R.
    ONCOLOGY-NEW YORK, 2016, 30 (08): : 713 - 721
  • [45] Update on Immune Checkpoint Inhibitors in Lung Cancer
    Creelan, Benjamin C.
    CANCER CONTROL, 2014, 21 (01) : 80 - 89
  • [46] Immune Checkpoint Inhibitors in Lung Cancer and Melanoma
    Madden, Kathleen
    Kasler, Mary Kate
    SEMINARS IN ONCOLOGY NURSING, 2019, 35 (05)
  • [47] Immune checkpoint inhibitors in lung cancer: an update
    Sullivan, Kevin
    Preeshagul, Isabel
    Budman, Daniel
    Seetharamu, Nagashree
    FUTURE ONCOLOGY, 2017, 13 (11) : 955 - 959
  • [48] Lower tumor volume is associated with increased benefit from immune checkpoint inhibitors in patients with advanced non-small-cell lung cancer
    Icht, Oded
    Domachevsky, Liran
    Groshar, David
    Dudnik, Elizabeth
    Rotem, Ofer
    Allen, Aaron M.
    Peled, Nir
    Reinhorn, Daniel
    Jacobi, Oded
    Shochat, Tzippy
    Bernstine, Hanna
    Zer, Alona
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (02) : E125 - E131
  • [49] Immune related endonucleases and GTPases are not associated with tumor response in patients with advanced non-small cell lung cancer treated with checkpoint inhibitors
    Ramdani, H. O.
    Falk, M.
    Heukamp, L. C.
    Schatz, S.
    Tiemann, M.
    Wesseler, C.
    Diehl, L.
    Schuuring, E.
    Groen, H. J. M.
    Griesinger, F.
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 227
  • [50] Maximum Somatic Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden Predicts the Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Dong, Yiting
    Zhu, Yixiang
    Zhuo, Minglei
    Chen, Xiaomin
    Xie, Yinpeng
    Duan, Jianchun
    Bai, Hua
    Hao, Shiguang
    Yu, Zicheng
    Yi, Yuting
    Guan, Yanfang
    Yuan, Jie
    Xia, Xuefeng
    Yi, Xin
    Wang, Jie
    Wang, Zhijie
    CANCERS, 2022, 14 (22)
12345